Treatment of Janus kinase inhibitors in rheumatoid arthritis

DOI

Bibliographic Information

Other Title
  • 関節リウマチにおけるヤヌスキナーゼ阻害薬の治療

Abstract

<p>The author examined the use of Janus kinase (JAK) inhibitors in patients with rheumatoid arthritis (RA) at our hospital: 8 patients were treated with tofacitinib, and 5 were treated with baricitinib. The tofacitinib treatment group consisted of 2 treatment-naïve patients and 6 patients switched from another treatment. Currently, tofacitinib treatment is being continued in 4 patients, and baricitinib treatment in 3 patients. The proportion of female patients was higher. The patients in this study were elderly. Methotrexate (MTX) was used in all patients. An improvement in the modified Health Assessment Questionnaire (mHAQ) score was observed with both drugs. Herpes zoster occurred in 5 patients receiving tofacitinib and 1 patient receiving baricitinib. In this report, patients treated with JAK inhibitors are presented and discussed.</p>

Journal

Details 詳細情報について

  • CRID
    1390848250131139456
  • NII Article ID
    130007879685
  • DOI
    10.15107/jcoa.m2-1
  • ISSN
    21897905
    18817149
  • Text Lang
    ja
  • Data Source
    • JaLC
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top